Patents by Inventor Richard D. Hamlin

Richard D. Hamlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10918607
    Abstract: Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix which includes the propynylaminoindan, a pressure sensitive adhesive that includes an acrylate copolymer and a cationic acrylic copolymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: February 16, 2021
    Assignee: Teikoku Pharma USA, Inc.
    Inventors: Richard D. Hamlin, Amit Jain, Jianye Wen
  • Patent number: 9913812
    Abstract: Methods of treating skin neoplasms using a monoamine oxidase inhibitor, e.g., a propynylaminoindan (such as rasagiline) are provided. Pharmaceutical compositions and kits comprising monoamine oxidase inhibitors are also provided.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: March 13, 2018
    Assignee: Teikoku Pharma USA, Inc.
    Inventors: Susan Meier-Davis, Jianye Wen, Richard D. Hamlin
  • Patent number: 9827207
    Abstract: Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix which includes the propynylaminoindan, a pressure sensitive adhesive that includes an acrylate copolymer and a cationic acrylic copolymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: November 28, 2017
    Assignee: Teikoku Pharma USA, Inc.
    Inventors: Richard D. Hamlin, Amit Jain, Jianye Wen
  • Patent number: 9597301
    Abstract: Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix of the propynylaminoindan in a pressure sensitive adhesive comprising a carboxylated polymer. In some instances, the matrix further includes a cationic acrylic copolymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
    Type: Grant
    Filed: March 16, 2015
    Date of Patent: March 21, 2017
    Assignee: Teikoku Pharma USA, Inc.
    Inventors: Jianye Wen, Richard D. Hamlin
  • Publication number: 20160184240
    Abstract: Transdermal compositions are provided. Aspects of the transdermal compositions include: an active agent layer and a conversion layer, where the conversion layer includes a weak base and, optionally, a carboxylated component. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
    Type: Application
    Filed: July 24, 2015
    Publication date: June 30, 2016
    Inventors: Richard D. Hamlin, Jianye Wen
  • Publication number: 20160051489
    Abstract: Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix which includes the propynylaminoindan, a pressure sensitive adhesive that includes an acrylate copolymer and a cationic acrylic copolymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
    Type: Application
    Filed: November 5, 2015
    Publication date: February 25, 2016
    Inventors: Richard D. Hamlin, Amit Jain, Jianye Wen
  • Patent number: 9205061
    Abstract: Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix which includes the propynylaminoindan, a pressure sensitive adhesive that includes an acrylate copolymer and a cationic acrylic copolymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: December 8, 2015
    Assignee: Teikoku Pharma USA, Inc.
    Inventors: Richard D. Hamlin, Amit Jain, Jianye Wen
  • Publication number: 20150182476
    Abstract: Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix of the propynylaminoindan in a pressure sensitive adhesive comprising a carboxylated polymer. In some instances, the matrix further includes a cationic acrylic copolymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
    Type: Application
    Filed: March 16, 2015
    Publication date: July 2, 2015
    Inventors: Jianye Wen, Richard D. Hamlin
  • Publication number: 20140186422
    Abstract: Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix which includes the propynylaminoindan, a pressure sensitive adhesive that includes an acrylate copolymer and a cationic acrylic copolymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
    Type: Application
    Filed: October 25, 2013
    Publication date: July 3, 2014
    Applicant: TEIKOKU PHARMA USA, INC.
    Inventors: Richard D. Hamlin, Amit Jain, Jianye Wen
  • Publication number: 20140127281
    Abstract: Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix which includes the propynylaminoindan, a pressure sensitive adhesive that includes an acrylate copolymer and a cationic acrylic copolymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.
    Type: Application
    Filed: October 25, 2013
    Publication date: May 8, 2014
    Inventors: Richard D. Hamlin, Amit Jain, Jianye Wen
  • Publication number: 20130302441
    Abstract: Methods of treating skin neoplasms using a monoamine oxidase inhibitor, e.g., a propynylaminoindan (such as rasagiline) are provided. Pharmaceutical compositions and kits comprising monoamine oxidase inhibitors are also provided.
    Type: Application
    Filed: November 2, 2012
    Publication date: November 14, 2013
    Inventors: Susan Meier-Davis, Jianye Wen, Richard D. Hamlin
  • Patent number: 6267984
    Abstract: Compositions, devices, and methods for transdermal administration of a drug are disclosed using a novel permeation enhancer mixture comprising a monoglyceride and ethyl palmitate. The monoglyceride/ethyl palmitate permeation enhancer is a potent permeation enhancer and provides stable systems which are more readily characterized. Additionally, ethyl palmitate cosolvent systems are more readily processed at manufacturing conditions thus providing further advantages over other cosolvents.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: July 31, 2001
    Assignee: ALZA Corporation
    Inventors: Russell D. Beste, Richard D. Hamlin
  • Patent number: 5843468
    Abstract: Compositions, devices, and methods for transdermal administration of an active agent are disclosed using a novel dual permeation enhancer mixture comprising lauryl acetate and a monoglyceride, preferably glycerol monolaurate. The dual permeation enhancer mixture comprising lauryl acetate is a potent permeation enhancer and provides stable systems which are more readily characterized.
    Type: Grant
    Filed: May 13, 1996
    Date of Patent: December 1, 1998
    Assignee: ALZA Corporation
    Inventors: Terry L. Burkoth, Lina T. Taskovich, Russell D. Beste, Robert M. Gale, Eun Soo Lee, Richard D. Hamlin, Su LL Yum